Skip to content

INNOVATION FUND

Active
Public limited companyfounded 201511 yrs activeAuguste Reyerslaan 70, 1030 Schaarbeek, BelgiumKBO/BCE: BE 0598.764.469
Summary

INNOVATION FUND has been active since 2015 and the Belgian State Gazette contains no insolvency or warning signals. The 2025 annual accounts show equity of €20.66M and a net result of €-2.62M. Equity is shrinking by ~5% per year across the filed fiscal years. The computed 12-month bankruptcy probability is 1.3% (low).

Checked score

Score 2025
57 / 100
Fair
The score weighs solvency, liquidity and profitability. Bankruptcy probability contributes 35%. Every signal that weighs is under Signals.
Axes · tick = 2024
Profitability6▲+6
Solvency100=
Growth32=
Track record100
Bankruptcy probability, 12 months
1.3% Low
0%0.5%1.5%4%10%≥ 25%
Credit up to €1.15M at 30 days acceptable
short-term debt: 0.1% and cash: 2.9% of total assets, and 0.1% of the assets are financed with debt.
Credit advice for your own amount and term

Signals

Seven signals. The signal on the left, the evidence on the right.
lowers risk+raises riskneutral
raises risk · No NACE activity registered
No NACE activity is registered in the KBO, which is more common among companies that later fail.
KBO · activities
raises risk · Higher-failure-rate region
In this region companies fail more often than in the rest of the country.
KBO · registered office
lowers risk · Annual accounts: healthy financial profile
The latest annual accounts show a healthy profile in solvency, result and liquidity.
NBB · annual accounts 2025
Solvency, return and age of the figures
Solvency
99.9%
Return on assets
-12.7%
Age of the figures
9 mo
lowers risk · Lower-risk legal form
Companies with this legal form statistically fail less often than a BV.
KBO · legal form
lowers risk · Long track record
A company with a long track record statistically fails less often than a young one.
KBO · incorporation date
Age against the risk zone
highest failure risk from 2 to 8 years 11 years 0 20 y
raises risk · Persistent losses
Two consecutive loss-making years (2024 and 2025); equity is also lower. May indicate structural pressure on profitability.
NBB · annual accounts 2025
Net result per financial year
1819202122232425
2018 to 2025 · latest year €-2.62M
neutral · Latest accounts filed on time
The financial year that closed on 31-12-2025 was due by 31-07-2026 and was filed on 27-07-2026, 4 days ahead of the deadline.
NBB · 6 filings
Deviation from the deadline
2025
4 d early
2024
34 d early
2023
21 d late
2022
29 d late
2021
22 d late
2020
46 d early
← before the deadline after the deadline →
Checked, nothing found (2)
neutral · The next deadline is still running
The next financial year closes on 31-12-2026 and is due by 31-07-2027. Nothing is late today.
Companies Code · seven months
Position in the running window
24-09-2026 today31-12-2026 close31-07-2027 deadline
neutral · No strike-offs in the KBO publications
We found no ex-officio strike-off or cessation. Our series starts in 2021 and has gaps, so this is not a confirmation that there is nothing.
KBO publications · our coverage

Financials · fiscal year 2025, full schema

Turnover
Not included in this filing
EBIT margin
Not included in this filing
Net result
€-2.62M▲ 64.6%
2024 · €-7.41M
2018: €272k 2019: €-250k 2020: €74k 2021: €3.58M 2022: €-2.27M 2023: €-4.63M 2024: €-7.41M
2018 → 2025
Working capital
€3.00M▼ 17.8%
2024 · €3.65M
2018: €18.35M 2019: €18.19M 2020: €12.13M 2021: €11.76M 2022: €4.32M 2023: €2.51M 2024: €3.65M
2018 → 2025
Multi-year overview
Every figure with its change against the year before
▲ rise ▼ fall
Line20212022202320242025Trend
Equity€37.59M-€35.32M▼ 6.0%€30.69M▼ 13.1%€23.28M▼ 24.1%€20.66M▼ 11.3%
Operating result€-510k-€-538k▼ 5.4%€-458k▲ 14.7%€-310k▲ 32.5%€-254k▲ 18.0%
Net result€3.58M-€-2.27M€-4.63M▼ 104%€-7.41M▼ 60.1%€-2.62M▲ 64.6%
Result per fiscal year
Operating resultNet result
€-10.00M€-5.00M€0€5.00MOperating result 2021: €-510k€-510kNet result 2021: €3.58M€3.58MOperating result 2022: €-538k€-538kNet result 2022: €-2.27M€-2.27MOperating result 2023: €-458k€-458kNet result 2023: €-4.63M€-4.63MOperating result 2024: €-310k€-310kNet result 2024: €-7.41M€-7.41MOperating result 2025: €-254k€-254kNet result 2025: €-2.62M€-2.62M20212022202320242025€-8M€-6M€-4M€-2M€0Operating result 2023: €-458k€-458kNet result 2023: €-4.63M€-4.6MOperating result 2024: €-310k€-310kNet result 2024: €-7.41M€-7.4MOperating result 2025: €-254k€-254kNet result 2025: €-2.62M€-2.6M202320242025
The operating result stays negative: a loss of €254k in 2025 against €310k in 2024; the loss shrinks.
Balance-sheet composition
2025 in colour, 2024 as the grey bar beneath
Assets €20.69M
Fixed assets €17.67M ▼ 10.0%
Current assets €3.02M ▼ 17.9%
Equity and liabilities €20.69M
Equity €20.66M ▼ 11.3%
Debt €29k ▼ 18.1%
Debt's share of the balance-sheet total stays at 0.1%.
Key figures and ratios
2025 value · change against 2024
Debt to equity
0.00
2024 · 0.00
ROE
-12.7%
2024 · -31.8%
ROA
-12.7%
2024 · -31.8%
Debt ≤ 1 year
€25k
2024 · €35k
A ratio outside any meaningful range has been withheld (balance sheet total €20.69M, equity €20.66M).
Green means a favourable move, even when the figure itself falls: as with debt or debt to equity.
Filed annual accounts As filed with the NBB · 2025 against 2024 · 40 lines
Balance sheet Code20242025
Assets
Total assets20/58€23.32M€20.69M
Fixed assets21/28€19.64M€17.67M
Financial fixed assets28€19.64M€17.67M
Current assets29/58€3.68M€3.02M
Amounts receivable within one year40/41€12k€33k
Other amounts receivable41€12k€33k
Current investments50/53€1.01M€2.30M
Cash at bank and in hand54/58€2.51M€607k
Deferred charges and accrued income490/1€142k€82k
Equity and liabilities
Total equity and liabilities10/49€23.32M€20.69M
Equity10/15€23.28M€20.66M
Contributions10/11€35.07M€35.07M=
Capital10€33.70M€33.70M=
Issued capital100€33.70M€33.70M=
Outside capital11€1.37M€1.37M=
Share premium1100/10€1.37M€1.37M=
Reserves13€126k€126k=
Non-distributable reserves130/1€126k€126k=
Legal reserve130€126k€126k=
Profit (loss) carried forward14€-11.91M€-14.53M
Amounts payable17/49€35k€29k
Amounts payable within one year42/48€35k€25k
Trade debts44€35k€25k
Suppliers440/4€35k€25k
Accrued charges and deferred income492/3-€4k
Income statement Code20242025
Depreciation of and write-downs on formation expenses, intangible and tangible fixed assets630€306-
Other operating charges640/8€968€1k
Gross operating margin9900€-308k€-253k
Operating profit (loss)9901€-310k€-254k
Financial income75/76B€2.08M€683k
Recurring financial income75€200k€133k
Non-recurring financial income76B€1.88M€550k
Financial charges65/66B€9.18M€3.05M
Recurring financial charges65€356k€15k
Non-recurring financial charges66B€8.82M€3.03M
Profit (loss) for the period before taxes9903€-7.41M€-2.62M
Profit (loss) for the period9904€-7.41M€-2.62M
Profit (loss) for the period to be appropriated9905€-7.41M€-2.62M
Appropriation of the result
Profit (loss) to be appropriated9906€-11.91M€-14.53M
Profit (loss) brought forward from the previous period14P€-4.50M€-11.91M

The notes to these accounts (8 items: statements of assets and debts, cost breakdowns, rights and commitments) are not shown here.

Download as CSV

Timeline · acts, filings and financial milestones

Next filing, fiscal year 2026, expected by 31-07-2027
2026
27-07
NBB filing Annual accounts filed
fiscal year 2025 · full schema
16-02
State Gazette act Resignations: Nathalie Brunelle (director) and Drita Delija (director)
Appointments: Olivier Greiner (director) and Yves Verschueren (director) · Mandate compensation7 facts ▸
  • General meeting, 10-06-2025
  • Director resignation, Nathalie Brunelle (director)
  • Director appointment, Olivier Greiner (director)
  • Director resignation, Drita Delija (director)
  • Director appointment, Yves Verschueren (director)
  • Mandate compensation, Olivier Greiner
  • Mandate compensation, Yves Verschueren
2025
27-06
NBB filing Annual accounts filed
fiscal year 2024 · full schema
27-06
NBB filing Annual accounts filed
fiscal year 2024 · abbreviated schema
27-05
State Gazette act Registered office
Registered-office move2 facts ▸
  • Board meeting, 26-02-2025
  • Registered-office move, Boulevard Auguste Reyers 70, 1030 Bruxelles
06-03
State Gazette act Appointments: Christophe Behiels, Jan Vergote and 2 others
Resignations: Peter Crauwels, Olivier Chapelle and 2 others · Reappointment: BST (statutory auditor) · Mandate compensation11 facts ▸
  • General meeting, 11-06-2024
  • Director appointment, Christophe Behiels (permanent representative)
  • Director resignation, Peter Crauwels (permanent representative)
  • Director appointment, Jan Vergote (permanent representative)
  • Director resignation, Olivier Chapelle (permanent representative)
  • Director appointment, Stijn Verbert (permanent representative)
  • Director resignation, Philip Buskens (permanent representative)
  • Director appointment, Christian Barrot (administrator)
  • Director resignation, Axel Roussis (administrator)
  • Mandate compensation, INNOVATION FUND
  • Auditor reappointment, BST
2024
31-12
Financial Weakest financial yearnet €-7.41M
Net result drops to €-7.41M, the lowest in the series; recovery starts the following year.
21-08
NBB filing Annual accounts filed
fiscal year 2023 · full schema · 21 days late
21-08
NBB filing Annual accounts filed
fiscal year 2023 · abbreviated schema · 21 days late
2023
31-08
State Gazette act Permanent representative: Helena Pozios
Mandate compensation3 facts ▸
  • General meeting, 13-06-2023
  • Permanent representative, Helena Pozios
  • Mandate compensation, Helena Pozios
29-08
NBB filing Annual accounts filed
fiscal year 2022 · full schema · 29 days late
29-08
NBB filing Annual accounts filed
fiscal year 2022 · abbreviated schema · 29 days late
Show earlier events
30-05
State Gazette act Permanent representatives: Alexis Ponnouradjou and Olivier Bouchat
Mandate compensation · Mandate term7 facts ▸
  • General meeting, 14-06-2022
  • Permanent representative, Alexis Ponnouradjou
  • Permanent representative, Olivier Bouchat
  • Mandate compensation, Alexis Ponnouradjou
  • Mandate compensation, Olivier Bouchat
  • Mandate term, 08-06-2027
  • Mandate term, 08-06-2027
2022
31-08
NBB filing Annual accounts filed
fiscal year 2021 · abbreviated schema · 22 days late
22-08
NBB filing Annual accounts filed
fiscal year 2021 · full schema · 22 days late
2021
31-12
Financial Highest result since 2018net €3.58M ▲4741%
Net result €3.58M, the highest in the series.
11-10
State Gazette act Reappointments: INNOVATION FUND (director) and BST (statutory auditor)
Permanent representatives: Peter Cauwels and Denis Bortzmeyer · Mandate compensation8 facts ▸
  • General meeting, 08-06-2021
  • Director reappointment, INNOVATION FUND (director)
  • Mandate compensation, INNOVATION FUND
  • Permanent representative, Peter Cauwels
  • Permanent representative, Denis Bortzmeyer
  • Mandate compensation, Peter Cauwels
  • Mandate compensation, Denis Bortzmeyer
  • Auditor reappointment, BST
15-06
NBB filing Annual accounts filed
fiscal year 2020 · full schema
2020
31-12
Financial Back to profitnet €74k
Net result €74k after one loss-making year.
31-12
Financial Liquidity quadruplescurrent ratio 1426.10
Current ratio from 398.37 to 1426.10; short-term debt falls from €46k to €9k.
22-09
State Gazette act Resignation: Koenraad Debackere (director)
Appointment: Ilse Sienaert (director) · Permanent representatives: Alexis Brouhns and Johan Keppens · Mandate compensation6 facts ▸
  • General meeting, 09-06-2020
  • Director resignation, Koenraad Debackere (director)
  • Director appointment, Ilse Sienaert (director)
  • Mandate compensation, Ilse Sienaert
  • Permanent representative, Alexis Brouhns
  • Permanent representative, Johan Keppens
21-01
State Gazette act Appointments: SOCIETE REGIONALE D'INVESTISSEMENT DE BRUXELLES, ESSENSCIA and INNOVATION FUND FEEDER
Permanent representatives: Pierre Hermant, Drita Delija and 2 others · Capital increase · Bank account14 facts ▸
  • General meeting, 15-10-2019
  • Capital increase, €6.100.000
  • Bank account, BE89 3631 8964 9285
  • Capital, €33.700.000
  • Director appointment, SOCIETE REGIONALE D'INVESTISSEMENT DE BRUXELLES (director)
  • Director appointment, ESSENSCIA (director)
  • Director appointment, INNOVATION FUND FEEDER (director)
  • Permanent representative, Pierre Hermant
  • Permanent representative, Drita Delija
  • Permanent representative, Patrick De Ruyttere
  • Permanent representative, Jos Behiels
  • Mandate compensation, INNOVATION FUND
  • +2 further facts in this act
2018
13-11
State Gazette act Reappointment: BST (statutory auditor)
2 facts ▸
  • General meeting, 12-06-2018
  • Auditor reappointment, BST
23-01
State Gazette act Appointments: CHRISTEYNS, UNIVERSITEIT GENT and 2 others
Permanent representative: Serge Demoulin · Capital increase · Bank account15 facts ▸
  • General meeting, 22-12-2017
  • Capital increase, €7.600.000
  • Bank account, ING, BE04 3631 6935 1431
  • Capital, €27.600.000
  • Director appointment, CHRISTEYNS (director)
  • Director appointment, UNIVERSITEIT GENT (director)
  • Director appointment, PARTICIPATIE MAATSCHAPPIJ VLAANDEREN NV (director)
  • Director appointment, HUTCHINSON (director)
  • Mandate compensation, CHRISTEYNS
  • Permanent representative, Serge Demoulin
  • Permanent representative resignation, Sylvie Creteur
  • Mandate compensation, UNIVERSITEIT GENT
  • +3 further facts in this act
2017
27-12
State Gazette act Capital & shares
Capital increase · Premium allocation · Power of attorney5 facts ▸
  • General meeting, 05-12-2017
  • Capital increase, €10.000.000
  • Premium allocation, prime d'émission comptabilisée à un compte de réserve indisponible
  • Power of attorney, Conseil d'administration
  • Payment requirement, 75% of share value + full premium must be paid upon subscription
24-10
State Gazette act Registered office · Statutes amendment · Resignations & appointments
Capital · Founding3 facts ▸
  • General meeting, 29-09-2017
  • Capital, €20.000.000
  • Founding, 10-02-2015
2016
11-07
State Gazette act Capital & shares
Capital increase · Bank account · Capital6 facts ▸
  • General meeting, 14-06-2016
  • Capital increase, €600.000
  • Bank account, 01-06-2016
  • Capital, €20.000.000
  • Statutes amendment
  • Power of attorney, TETRA LAW
16-06
State Gazette act Capital & shares
Capital increase · Power of attorney · Share payment requirement7 facts ▸
  • General meeting, 27-05-2016
  • Capital increase, €600.000
  • Power of attorney, Conseil de gérance
  • Share payment requirement, 25%
  • Share numbering, 389-400
  • Pre emption negotiability, négociable durant le délai de souscription
  • Pre emption reversion, le conseil d'administration pourra décider si les tiers peuvent participer à l'augmentation ou si les droits de préférence n'ayant pas ou n'ayant été que partie…
22-03
State Gazette act Appointments: Christian Collette (director) and Luc REGINSTER (director)
Capital increase · Share issue · Capital10 facts ▸
  • General meeting, 04-02-2016
  • Capital increase, €2.100.000
  • Share issue, 42, 50000.00
  • Capital, €19.400.000
  • Registered-office move, Allée de la Recherche 12, 1070 Bruxelles
  • Director appointment, Christian Collette (director)
  • Director appointment, Luc REGINSTER (director)
  • Mandate compensation, Christian Collette
  • Mandate compensation, Luc REGINSTER
  • Power of attorney, TETRA LAW
2015
21-10
State Gazette act Reappointment: Koenraad DEBACKERE (director)
Appointments: BASF ANTWERPEN (director) and Paul DEPUYDT (director) · Permanent representative: Philip BUSKENS · Capital increase10 facts ▸
  • General meeting, 06-10-2015
  • Capital increase, €4.300.000
  • Share issue, 86, 50000.00
  • Capital, €17.300.000
  • Statutes amendment
  • Director reappointment, Koenraad DEBACKERE (director)
  • Director appointment, BASF ANTWERPEN (director)
  • Permanent representative, Philip BUSKENS
  • Director appointment, Paul DEPUYDT (director)
  • Power of attorney, INNOVATION FUND
15-09
State Gazette act Resignation: KU Leuven (director)
Appointment: Koenraad Debackere (director)3 facts ▸
  • Board meeting, 27-03-2015
  • Director resignation, KU Leuven (director)
  • Director appointment, Koenraad Debackere (director)
Financial milestoneState Gazette actNBB filingFinancial milestones sit on the fiscal year-end date, not the filing date.An act published in both Dutch and French appears here once.

Directors · office · real estate

Directors
18 directors, no change since 2025
Olivier Greiner
Director · since 10-06-2025
Current
Yves Verschueren
Director · since 10-06-2025
Current
Christian Barrot
Administrator · since 11-06-2024
Current
Christophe Behiels
Permanent representative · since 11-06-2024
Current
Jan Vergote
Permanent representative · since 11-06-2024
Current
Stijn Verbert
Permanent representative · since 11-06-2024
Current
12 other directors
Ilse Sienaert
Director · since 09-06-2020
Not recently confirmed
FEDERATION BELGE DES INDUSTRIES CHIMIQUES ET DES SCIENCES DE LA VIE
Director · since 15-10-2019 · Non-profit association · perm. rep.: Drita Delija
Not recently confirmed
finance&invest.brussels
Director · since 15-10-2019 · Public limited company · perm. rep.: Pierre Hermant
Not recently confirmed
INNOVATION FUND FEEDER
Director · since 15-10-2019 · Legal entity · perm. rep.: Patrick De Ruyttere
Not recently confirmed
INNOVATION FUND FEEDER
Director · since 15-10-2019 · Without legal personality · perm. rep.: Patrick De Ruyttere
Not recently confirmed
CHRISTEYNS
Director · since 22-12-2017 · Public limited company
Not recently confirmed
HUTCHINSON
Director · since 22-12-2017 · Legal entity
Not recently confirmed
Participatiemaatschappij Vlaanderen
Director · since 22-12-2017 · Public limited company
Not recently confirmed
Universiteit Gent
Director · since 22-12-2017 · Andere rechtsvorm
Not recently confirmed
Christian Collette
Director · since 04-02-2016
Not recently confirmed
Luc REGINSTER
Director · since 04-02-2016
Not recently confirmed
BASF Antwerpen
Director · since 06-10-2015 · Public limited company · perm. rep.: Philip BUSKENS
Not recently confirmed
10-06-2025 Olivier Greiner: Appointed as Director
10-06-2025 Yves Verschueren: Appointed as Director
10-06-2025 Drita Delija: Resigned as Director
10-06-2025 Nathalie Brunelle: Resigned as Director
11-06-2024 Christian Barrot: Appointed as Administrator
Full history in the Timeline (36 changes) →
Location & real-estate footprint
Registered office, Schaarbeek · 1 establishment unit since 2015
establishment The establishment unit on the map
Cannot be placed on the map

This address could not be matched to a point in the Belgian address register (BOSA BEST). The address below comes straight from the Crossroads Bank.

Auguste Reyerslaan 701030 Schaarbeek
Ground area
7,530 m²
Building footprint
3,037 m²
Volume, LiDAR
84,150 m³
Parcel 21911C0131/03F000, Brussels · tallest building 33.0 m, ±9 floors. Linked by address, not a title deed.
1 establishment unit
INNOVATION FUND
Auguste Reyerslaan 70, 1030 SchaarbeekHoldings
since 20152.245.465.866
1 parcel
Brussels 1 (100%)
Parcel (capakey) Region Area Buildings Height / fl.
21911C0131/03F000 Brussels 7,530 m² 1 · 3,037 m² 33.0 m · 9 fl.
Linked by address, not proof of ownership
Methodology
via registered seat: 1
1 of 1 parcel with an exact address match; the rest are indicative.
Linked through address data, this is not proof of ownership.

Statutory auditor

1 auditor
BSTCurrent
Auditor · represented by e14
12-06-2018 → present

Articles of association

Purpose
Investeren in vennootschappen en financieren van ondernemingen
Full purpose

Investeren in vennootschappen en financieren van ondernemingen.

Structure & network

Connections & network

99 connected companies
Yves Verschueren, Shared director, links 8 companies YVYves Verschuerencentre de jour et centre d'hebergement pour adultes ayant une déficience motrice cérébrale, via Yves Verschueren CDcentre de jouret centre…CONSEIL EUROPEEN DE L'INDUSTRIE CHIMIQUE - EUROPEAN CHEMICAL INDUSTRY COUNCIL, via Yves Verschueren CECONSEILEUROPEEN DE…FEDERATION DES ENTREPRISES DE BELGIQUE - VERBOND VAN BELGISCHE ONDERNEMINGEN - VERBAND DER BELGISCHEN UNTERNEHMEN, via Yves Verschueren FDFEDERATION DESENTREPRISES…ICC Belgique, via Yves Verschueren IBICC BelgiqueCentre National de Prévention et de Traitement des Intoxications, via Yves Verschueren CNCentreNational de…FEDERATION DE L'INDUSTRIE ALIMENTAIRE - FEDERATIE VOEDINGSINDUSTRIE, via Yves Verschueren FDFEDERATION DEL'INDUSTRIE…Federation of Belgian Industrial Energy Consumers, via Yves Verschueren FOFederation ofBelgian…UNILEVER BELGIUM, via Yves Verschueren UBUNILEVERBELGIUMOlivier Greiner, Shared director, links 5 companies OGOlivier GreinerFEDERATION BELGE DES ENTREPRISES ELECTRIQUES ET GAZIERES, via Olivier Greiner FBFEDERATIONBELGE DES…LAMPIRIS-ISOL, via Olivier Greiner LLAMPIRIS-ISOLTotalEnergies Power & Gas Belgium, via Olivier Greiner TPTotalEnergiesPower & Gas…LOWER OLEFINS & AROMATICS, via Olivier Greiner LOLOWER OLEFINS& AROMATICSINNOVATION FUND INNOVATIONFUND0598.764.469
Shared directors
Linked via shared directors
Show 95 more companies with a shared director
former
Fedustria
via Jan Vergote · Director
former
former
ADD
Shared director
AGORIA
Shared director
Alumni Lovanienses
Shared director
ANTWERP SPACE
Shared director
ASSOCIATIE KU Leuven
Shared director
BOPLICITY
Shared director
Complix
Shared director
De Eik
Shared director
InOpSys
Shared director
JOOS
Shared director
KBC ASSET MANAGEMENT
Shared director
KBC ASSURANCES
Shared director
KBC Bank
Shared director
KBC Global Services
Shared director
KBC Groupe
Shared director
LUCA School of Arts
Shared director
MIJNEN
Shared director
QUEST FOR GROWTH
Shared director
SYNEPEIA
Shared director
TELEVIC GROUP
Shared director
Thomas More Kempen
Shared director
THOR PARK
Shared director
UMICORE
Shared director
Z.org KU Leuven
Shared director
Aelin Therapeutics
Shared corporate director
Aphea.Bio
Shared corporate director
Banqup Group
Shared corporate director
BASF Werknemers en Tariefbedienden
Shared corporate director
Belgian Offshore Platform
Shared corporate director
BELWIND
Shared corporate director
BLUE GATE ANTWERP PUBLIC HOLDING
Shared corporate director
Brusoc by finance&invest.brussels
Shared corporate director
Catalisti
Shared corporate director
CITYMESH INTEGRATOR
Shared corporate director
Confo Therapeutics
Shared corporate director
DBFM Scholen van Morgen
Shared corporate director
De Werkvennootschap
Shared corporate director
DEME BLUE ENERGY
Shared corporate director
FEops
Shared corporate director
färm.coop
Shared corporate director
GIGARANT
Shared corporate director
GOVI PRODUCTION COMPANY
Shared corporate director
HERSELF
Shared corporate director
Hubspot Belgium
Shared corporate director
Hydro Global Solution
Shared corporate director
iFLUX
Shared corporate director
Indigo Diabetes
Shared corporate director
InvestSuite
Shared corporate director
MyCartis
Shared corporate director
ORSI Academy
Shared corporate director
PARKWIND
Shared corporate director
Plopsa Station Antwerp
Shared corporate director
PMV - Standaardleningen
Shared corporate director
PROMAN Agilitas
Shared corporate director
REIN4CED
Shared corporate director
RENEWABLE ENERGY BASE OSTEND
Shared corporate director
ReWind Therapeutics
Shared corporate director
RheaVita
Shared corporate director
ST Engineering iDirect (Europe) CY
Shared corporate director
STORM HOLDING 2
Shared corporate director
SupplyStack
Shared corporate director
THE BELGIAN CHOCOLATE EXPERIENCE
Shared corporate director
THEODORUS IV
Shared corporate director
TRENDMINER
Shared corporate director
VERIDE
Shared corporate director
Veride Management
Shared corporate director
Vlaams Energiebedrijf
Shared corporate director
WANDELAAR INVEST
Shared corporate director

Ownership & control

1 board mandate
Board mandates of this companythis company sits on their board1

Capital and shareholders

Shareholders according to the acts
After the capital increase act of 21-01-2020 ↗
After the capital increase act of 23-01-2018 ↗
After the capital increase act of 11-07-2016 ↗

The Belgian State Gazette names shareholders only when an act mentions them; the share register itself is not published.

Capital over the years
  1. 21-01-2020 Capital increase of 6,100,000 EUR · to 33,700,000 EUR · 122 new shares
  2. 23-01-2018 Capital increase of 7,600,000 EUR · to 27,600,000 EUR · 152 new shares
  3. 27-12-2017 Capital increase of 10,000,000 EUR · to 30,000,000 EUR · 200 new shares
  4. 24-10-2017 Capital stated in the act · 20,000,000 EUR · 400 shares
  5. 11-07-2016 Capital increase of 600,000 EUR · to 20,000,000 EUR · 12 new shares
  6. 16-06-2016 Capital increase of 600,000 EUR · to 20,000,000 EUR · 12 new shares
  7. 22-03-2016 Capital increase of 2,100,000 EUR · to 19,400,000 EUR · 42 new shares · in cash
  8. 21-10-2015 Capital increase of 4,300,000 EUR · to 17,300,000 EUR · 86 new shares · in cash

Recognitions · licences · registrations

Legal Entity Identifier

875500MUYKOUAXVK2D54
live in the LEI register

Company data · Crossroads Bank

Identification
Legal formPublic limited company
Founded18-02-2015
Fiscal year end31-12
Sources
Crossroads Bank for EnterprisesNational Bank · 19 filingsAddress and cadastre registers

Scores and ratios are computed by Checked and are not a credit decision.